Toxicity profile of antibody-drug conjugates in breast cancer: practical considerationsA. D'Arienzo, Filippo Montemurro, Roberta Caputo et al.|EClinicalMedicine|2023Cited by 90
Assessment of Total, PTEN–, and AR-V7+ Circulating Tumor Cell Count by Flow Cytometry in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving EnzalutamideGiuseppe Di Lorenzo, Carlo Buonerba, Silvia Zappavigna et al.|Clinical Genitourinary Cancer|2021Cited by 23
Palbociclib added to ongoing endocrine therapy for hormone receptor‑positive HER2‑negative metastatic breast cancer: A case report seriesFrancesco Schettini, Grazia Arpino, Irene De Santo et al.|Molecular and Clinical Oncology|2020Cited by 2